Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)-Reference-Cited by-同舟云学术

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)

Published:2016-08 Issue: Volume:Volume 10 Page:2599-2609
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Park Jin-Sun,Shin Joon-Han,Hong Taek Jong,Seo Hong-Seog,Shim Wan-Joo,Baek Sang-Hong,Jeong Jin-Ok,Ahn Youngkeun,Kang Woong-Chol,Kim Young-Hak,Kim Sang Hyun,Hyon Min-Su,Choi Dong-Hoon,Nam Chang-Wook,Park Tae-Ho,Lee Sang-Chol,Kim Hyo-Soo

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease;Nature Medicine;2024-03-26

2. Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment;Exploration;2024-03-05

3. The Impact of Polypill on Adherence and Cardiovascular Outcomes: A Comprehensive Systematic Review with Meta-Analysis;Current Cardiology Reviews;2024-03

4. Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double‐blind, multicenter, therapeutic confirmatory, phase III clinical trial;The Journal of Clinical Hypertension;2024-02-06

5. A novel sustainable second‐derivative synchronous spectrofluorimetric method for the simultaneous determination of olmesartan medoxomil and rosuvastatin calcium in bulk and formulations: Integrated greenness and whiteness evaluation;Luminescence;2023-12-07